Orion Corporation
Orion Corporation (Finnish: Orion Oyj),[2][3] founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.
 | |
Native name | Orion Oyj |
|---|---|
| Julkinen osakeyhtiö | |
| Traded as | Nasdaq Helsinki: ORNAV,ORNBV |
| ISIN | FI0009800346  |
| Industry | Pharmaceutical industry |
| Founded | 1917 |
| Headquarters | Espoo, Finland |
Key people | Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman) |
| Products | Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests |
| Revenue |  |
| |
| |
| Total assets | |
| Total equity | |
Number of employees | |
| Website | www |
| Footnotes / references [1] | |
Orion's class A and B shares are listed on the Helsinki Stock Exchange.
Products
|
References
- https://www.orion.fi/globalassets/documents/orion-group/investors/annual-reports/orion-financial-statement-documents-2016.pdf
- "Orion Oyj". Business Information System. Finnish Patent and Registration Office and Finnish Tax Administration. Retrieved 22 October 2019.
- "Yhtiöjärjestys" [Corporate by-laws] (in Finnish). Espoo: Orion Oyj. 22 March 2017. Retrieved 22 October 2019.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.